» Articles » PMID: 34676021

The Critical Role of Oxidative Stress in Sarcopenic Obesity

Overview
Publisher Wiley
Date 2021 Oct 22
PMID 34676021
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Sarcopenic obesity (SO) is a combination of obesity and sarcopenia that primarily develops in older people. Patients with SO have high fat mass, low muscle mass, low muscle strength, and low physical function. SO relates to metabolic syndrome and an increased risk of morbimortality. The prevalence of SO varies because of lacking consensus criteria regarding its definition and the methodological difficulty in diagnosing sarcopenia and obesity. SO includes systemic alterations such as insulin resistance, increased proinflammatory cytokines, age-associated hormonal changes, and decreased physical activity at pathophysiological levels. Interestingly, these alterations are influenced by oxidative stress, which is a critical factor in altering muscle function and the generation of metabolic dysfunctions. Thus, oxidative stress in SO alters muscle mass, the signaling pathways that control it, satellite cell functions, and mitochondrial and endoplasmic reticulum activities. Considering this background, our objectives in this review are to describe SO as a highly prevalent condition and look at the role of oxidative stress in SO pathophysiology.

Citing Articles

Oxidative balance score is associated with increased risk of sarcopenia and sarcopenic obesity in non-elderly adults: results from NHANES 2011-2018.

Wang Z, Xu Q, Zhang Y, Wu R, Cui J, Zhou J Nutr Metab (Lond). 2025; 22(1):23.

PMID: 40069772 PMC: 11899308. DOI: 10.1186/s12986-025-00914-3.


Medical Nutrition Therapy and Physical Exercise for Acute and Chronic Hyperglycemic Patients with Sarcopenia.

Abad-Gonzalez A, Veses S, Argente Pla M, Civera M, Garcia-Malpartida K, Sanchez C Nutrients. 2025; 17(3).

PMID: 39940355 PMC: 11820730. DOI: 10.3390/nu17030499.


Sarcopenic Obesity: A Comprehensive Approach for Postmenopausal Women.

Park J, Chung Y, Song J, Kil K, Lee H, Chae J J Menopausal Med. 2025; 30(3):143-151.

PMID: 39829191 PMC: 11745730. DOI: 10.6118/jmm.24004.


Age-related changes in bioelectrical impedance analysis-derived phase angle (PhA) and the association between PhA and sarcopenic obesity in Chinese adults.

Luo X, Jin W Medicine (Baltimore). 2025; 104(2):e41122.

PMID: 39792740 PMC: 11730410. DOI: 10.1097/MD.0000000000041122.


Bridging the Gap: Supplements Strategies from Experimental Research to Clinical Applications in Sarcopenic Obesity.

Virgolici B, Dobre M, Stefan D Curr Issues Mol Biol. 2024; 46(12):13418-13430.

PMID: 39727928 PMC: 11726983. DOI: 10.3390/cimb46120800.


References
1.
Carrascosa J, Andres A, Ros M, Bogonez E, Arribas C, Fernandez-Agullo T . Development of insulin resistance during aging: involvement of central processes and role of adipokines. Curr Protein Pept Sci. 2011; 12(4):305-15. DOI: 10.2174/138920311795906655. View

2.
Salisbury D, Bronas U . Reactive oxygen and nitrogen species: impact on endothelial dysfunction. Nurs Res. 2014; 64(1):53-66. DOI: 10.1097/NNR.0000000000000068. View

3.
Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D . Oxidative stress, aging, and diseases. Clin Interv Aging. 2018; 13:757-772. PMC: 5927356. DOI: 10.2147/CIA.S158513. View

4.
Kim Y, Lee Y, Chung Y, Lee D, Joo N, Hong D . Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys. J Gerontol A Biol Sci Med Sci. 2012; 67(10):1107-13. DOI: 10.1093/gerona/gls071. View

5.
Han T, Tajar A, Lean M . Obesity and weight management in the elderly. Br Med Bull. 2011; 97:169-96. DOI: 10.1093/bmb/ldr002. View